China Regulation in Year Of The Dragon: Good Distribution Practice, Corporate Law, Export Bans
NMPA Raises Distributor Bar
A plethora of new and revised regulations in China to regulate drug distribution and storage, the set up of new corporations, administrative appeals, as well as the export of gene editing technology, are set to come into effect in 2024, ushering in more challenges to pharma and life sciences companies operating in the country.